Roundup: Pfizer completes acquisition of ResApp and different data

Pfizer completes buy of ResApp for over $115 million

Biopharmaceutical large Pfizer has accomplished its acquisition of ASX-listed digital well being startup ResApp for A$179 million ($116 million), based on the College of Queensland.

Brisbane-based ResApp has developed a cell app that analyzes cough sounds and diagnoses respiratory ailments, together with bronchial asthma, pneumonia, bronchiolitis, croup and power obstructive pulmonary illness. The corporate additionally just lately demonstrated its app’s capability to diagnose COVID-19.

Accredited to be used in Australia and Europe, ResAppDx will be built-in into telehealth platforms, emergency departments and first care settings.

New NHMRC-supported heart will apply AI to breast most cancers danger classification

A risk-based method utilizing AI will probably be utilized to a brand new breast most cancers screening heart launched on the College of Melbourne.

Supported by the Nationwide Well being and Medical Analysis Council (NHMRC), Australia’s main statutory authority for medical analysis, the My Breast Most cancers RISK Middle (MyBRISK) will use AI to investigate thousands and thousands of mammograms to establish “danger elements danger primarily based on extra highly effective mammography”.

These automated measures, mixed with household historical past, life-style and genetic testing, will enable the exams to higher rank girls of all ages for breast most cancers danger, the college mentioned in a press launch.

As present breast most cancers danger evaluation instruments are seemingly ‘unwieldy and inaccurate’, this new NHMRC Middle of Analysis Excellence goals to ‘create pathways for simpler customized screening’.

MyBRISK is a collaboration between the College of Melbourne, St Vincent’s Hospital Melbourne, Monash College, College of Western Australia, Queensland College of Expertise and Most cancers Council Victoria.

Digital software reduces treatment errors in kids’s hospitals: analysis

New analysis in Sydney has demonstrated how the usage of an digital treatment administration system (eMeds) may help scale back treatment errors in kids’s hospitals.

Led by Macquarie College, Sydney Kids’s Hospital and eHealth NSW, the examine concerned reviewing greater than 43,000 drug prescriptions for round 8,000 pediatric sufferers.

eMeds, which is now utilized in 200 hospitals in New South Wales to prescribe, dispense and provide medicines to sufferers, was developed by eHealth NSW. The know-how additionally helps monitor interactions and doses and supplies security alerts to forestall errors.

Townsville College Hospital Implements Dell Information Storage Options

Townsville College Hospital (TUH), a tertiary referral hospital in North Queensland, has deployed information storage options from Dell Applied sciences to enhance data sharing and high quality of care.

In line with a press launch, the hospital has adopted Dell PowerStore, a singular storage platform that gives block storage and a centralized information lake. It grew to become the idea for its ward administration and affected person movement reporting methods, resulting in “important progress” in medical media and enabled workers to report in close to actual time as a substitute of remedy. in batches.

TUH additionally carried out Dell PowerScale, which supplies a single repository for unstructured information.

“Collectively, the brand new storage options present TUH with extra efficiency, improved redundancy, scalability and suppleness,” Dell mentioned in an announcement.